RZCQT65Reinsurance Group of America, Incorporated·NYSE
25.19-0.67%
TA
Loading chart...
Screen all →
Snapshot
Index—P/E1.11EPS (ttm)22.76Insider Own0.48%Shs Outstand67.00MPerf Week0.24%
Market Cap1.69BForward P/E—EPS next Y—Insider Trans-4.98%Shs Float—Perf Month-0.43%
Enterprise Value1.73BPEG—EPS next Q—Short Float—Perf Quarter-1.49%
Income1.51BP/S0.07EPS this Y—Short Ratio0.69Perf Half Y-1.06%
Sales25.68BP/B0.12EPS next Y—ROA0.90%Short Interest49.00KPerf YTD-0.98%
Book/sh205.74P/C0.30EPS next 5Y—ROE11.29%52W High25.88 -2.67%Perf Year-1.37%
Cash/sh84.57P/FCF0.32EPS past 3/5Y32.30% 22.90%ROIC0.90%52W Low24.74 1.82%Perf 3Y-0.43%
Dividend Est.1.78 (7.07%)EV/EBITDA0.76Sales past 3/5Y12.80% 9.34%Gross Margin25.18%Volatility1.00% 0.80%Perf 5Y—
Dividend TTM1.78 (7.07%)EV/Sales0.07EPS Y/Y TTM97.57%Oper. Margin7.31%ATR (14)0.20Perf 10Y—
Dividend Ex-DateDec 31, 2026Quick Ratio—Sales Y/Y TTM18.59%Profit Margin5.87%RSI (14)49.36Recom—
Dividend Gr. 3/5Y47.58% —Current Ratio—EPS Q/Q229.26%SMA200.40%Beta0.10Target Price—
Payout16.18%Debt/Eq0.41Sales Q/Q19.46%SMA50-0.61%Rel Volume0.48Prev Close25.36
Employees3,900LT Debt/Eq0.41EarningsMay 07SMA200-1.00%Avg Volume75.90KPrice25.19
IPO DateOct 12, 2022Option/ShortYes / YesEPS/Sales Surpr.—Net Debt/EBITDA0.02Volume36,420Change-0.67%
Latest News· Times ET
Company

Reinsurance Group of America, Inc. functions as a holding company, concentrating on both conventional and cutting-edge life and health reinsurance offerings. Its operations are structured across five primary segments: the U.S. and Latin America, Canada, Europe, the Middle East and Africa (EMEA), Asia Pacific, and a distinct Corporate and Other division. The U.S. and Latin America segment is responsible for marketing individual and group life and health reinsurance to clients within its region, employing various agreement types such as yearly renewable term, coinsurance, and modified coinsurance. In Canada, the company's focus is on individual life reinsurance, supplemented by a lesser extent of creditor, group life and health, critical illness, and disability reinsurance, generally through yearly renewable term and coinsurance contracts. The EMEA segment provides individual and group life and health products, including critical illness coverage—which offers a benefit upon the diagnosis of a specified illness—and underwritten annuities, typically facilitated via yearly renewable term and coinsurance agreements. The Asia Pacific segment covers individual and group life and health reinsurance, critical illness coverage, disability, and superannuation, predominantly structured with yearly renewable term and coinsurance agreements. Finally, the Corporate and Other segment encompasses investment income from unallocated assets, investment-related gains and losses, and service fee revenues. Founded in 1973, the company's corporate headquarters are situated in Chesterfield, Missouri.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue25,67522,79122,04318,392—————
Cost of Goods Sold Incl. D&A19,20917,00319,55516,061—————
Gross Profit6,4665,7882,4882,331—————
Selling, General and Administrative Excl. Other
0000—————
Research and Development
0000—————
Other Operating Expense4,5904,2481,5081,171—————
Operating Income1,8761,5409801,160—————
Interest Expense396366304257—————
Unusual Expense
—————————
Non-Operating Income (Expense)396366304257—————
Net Income Before Taxes1,8761,5409801,160—————
Income Taxes361351256251—————
Consolidated Net Income1,5081,182717902—————
Net Income From Continuing Operations1,5151,189724909—————
Net Income1,5081,182717902—————
EPS (Recurring)23.0217.9410.9013.60—————
EPS (Basic, Before Extraordinaries)23.0217.9410.9013.60—————
EPS (Diluted)22.7617.6910.7313.44—————
EBITDA2,2731,9491,3301,458—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio1.111.442.401.94—————
Price To Sales Ratio0.060.070.080.10—————
Gross Margin25.1825.4011.2912.67—————
Operating Margin7.316.764.456.31—————
Net Margin5.875.193.254.90—————
Shares Outstanding66666667—————
Market Capitalization1,6631,6791,7031,747—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$26.36$25.95$25.55$25.14$24.73● Close Price0.00M0.53M1.06M1.59M2.12MUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
PORTER JONATHANEVP, Global Chief Risk OfficerAug 12 '26Sale246.308,5892,115,46014,885Aug 17
HERRMANN RONALDExecutive Vice PresidentAug 11 '26Option Exercise159.6910,8021,724,9868,698Aug 13
PORTER JONATHANEVP, Global Chief Risk OfficerAug 11 '26Option Exercise123.2117,3112,132,97324,928Aug 13
To My ChiEVP, Chief Legal OfficerJun 06 '26Option Exercise0.005,66106,040Jun 29
Hayden John W.EVP, ControllerMay 20 '26Sale214.9541488,98920,949May 22
Hayden John W.EVP, ControllerMay 20 '26Option Exercise129.801,867242,33722,816May 22
HERRMANN RONALDExecutive Vice PresidentMay 14 '26Sale210.587,0001,474,0423,938May 18
Cockrill LauraEVP & Chief Strategy OfficerMar 12 '26Option Exercise205.001,079221,1953,125Mar 16
Ozeki ArthurEVP, Head of Asia PacificMar 12 '26Option Exercise205.002,689551,24513,036Mar 16
Hayden John W.EVP, ControllerMar 12 '26Option Exercise205.002,252461,66021,605Mar 16
PORTER JONATHANEVP, Global Chief Risk OfficerMar 12 '26Option Exercise205.005,4561,118,48017,806Mar 16
CHENG TONY KIN SHUNPresident and CEOMar 12 '26Option Exercise205.0017,3883,564,54050,123Mar 16
HERRMANN RONALDEVPMar 12 '26Option Exercise205.006,5761,348,08013,795Mar 16
BARBI LESLIEEVP, Chief Investment OfficerMar 12 '26Option Exercise205.008,4301,728,15024,288Mar 16
Wainwright SimonExec. Advisor to CEOMar 12 '26Option Exercise205.002,239458,99516,182Mar 16
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.